MRI Reveals Early Synovial Changes With RA Treatment

MRI Reveals Early Synovial Changes With RA Treatment

Highly sensitive MRI evaluations confirmed the ability of tofacitinib (Xeljanz) to reduce synovial inflammation in patients with early rheumatoid arthritis (RA), researchers reported. On a validated MRI score for RA (RAMRIS), the change in bone marrow

(Visited 1 times, 1 visits today)
6
Like
Save

Comments

Comments are disabled for this post.